Intuitive Surgical (0R29) Share Forecast & Price Target

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0R29 Analyst Ratings

Strong Buy

18 Buy

2 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0R29 Stock 12 Month Forecast

Average Price Target

$498.26

▲(33.98% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $498.26 with a high forecast of $685.00 and a low forecast of $391.00. The average price target represents a 33.98% change from the last price of $371.90.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"353":"$353","686":"$686","436.25":"$436.3","519.5":"$519.5","602.75":"$602.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":685,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$685.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":498.2631578947368,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$498.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":391,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$391.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[353,436.25,519.5,602.75,686],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,400.19,422.09846153846155,444.00692307692304,465.9153846153846,487.82384615384615,509.7323076923077,531.6407692307693,553.5492307692307,575.4576923076922,597.3661538461538,619.2746153846153,641.1830769230769,663.0915384615384,{"y":685,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,400.19,407.7340890688259,415.2781781376518,422.8222672064777,430.36635627530364,437.9104453441295,445.45453441295547,452.99862348178135,460.5427125506073,468.0868016194332,475.6308906882591,483.174979757085,490.7190688259109,{"y":498.2631578947368,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,400.19,399.4830769230769,398.7761538461538,398.0692307692308,397.3623076923077,396.6553846153846,395.9484615384615,395.2415384615385,394.5346153846154,393.8276923076923,393.1207692307692,392.4138461538462,391.7069230769231,{"y":391,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":439.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":532.999,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":570.02,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.304,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.89,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.13,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":458.55,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":416.42,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.25,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.27,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":369.29,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":400.19,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$685.00

Average Price Target$498.26

Lowest Price Target$391.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jayson Bedford

Raymond James

$483→$480

Buy

29.07%

Upside

Reiterated

10/21/26

Intuitive Surgical price target lowered to $480 from $483 at Raymond JamesIntuitive Surgical price target lowered to $480 from $483 at Raymond James

Adam Maeder

Piper Sandler

$470

Buy

26.38%

Upside

Reiterated

10/21/26

Piper Sandler Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Anthony Petrone

Mizuho Securities

$415→$400

Hold

7.56%

Upside

Reiterated

10/21/26

Intuitive Surgical price target lowered to $400 from $415 at MizuhoIntuitive Surgical price target lowered to $400 from $415 at Mizuho

Robbie Marcus

J.P. Morgan

$450→$475

Buy

27.72%

Upside

Assigned

10/21/26

Intuitive Surgical price target raised to $475 from $450 at JPMorganIntuitive Surgical price target raised to $475 from $450 at JPMorgan

Suraj Kalia

Oppenheimer

$500

Buy

34.44%

Upside

Reiterated

10/21/26

Intuitive Surgical (ISRG) Receives a Buy from Oppenheimer

Mike Kratky

Leerink Partners

$473→$503

Buy

35.25%

Upside

Reiterated

10/21/26

Intuitive Surgical price target raised to $503 from $473 at LeerinkIntuitive Surgical price target raised to $503 from $473 at Leerink

Christopher Pasquale

Barclays

$485→$500

Buy

34.44%

Upside

Reiterated

10/21/26

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Hans Engel

Erste Group

―

Buy

―

Upgraded

10/21/26

Intuitive Surgical upgraded to Buy from Hold at Erste GroupIntuitive Surgical upgraded to Buy from Hold at Erste Group

David Rescott

Robert W. Baird

$513→$550

Buy

47.89%

Upside

Reiterated

10/21/26

Intuitive Surgical price target raised to $550 from $513 at BairdIntuitive Surgical price target raised to $550 from $513 at Baird

Larry Biegelsen

Wells Fargo

$487→$486

Buy

30.68%

Upside

Assigned

10/21/26

Wells Fargo Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

$470

Buy

26.38%

Upside

Reiterated

10/21/26

Intuitive Surgical: Strong Q3 Beat, Extended-Use Instruments and 2027 Pipeline Drive Buy Rating with Unchanged $470 Target

Rick Wise

Stifel Nicolaus

$550

Buy

47.89%

Upside

Reiterated

10/21/26

Stifel Nicolaus Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Lee Hambright

Bernstein

$685

Buy

84.19%

Upside

Reiterated

10/21/26

Intuitive Surgical: Buy Rating Reaffirmed as Strong Fundamentals and Innovation Pipeline Support Unchanged $685 Price Target

Ryan Zimmerman

BTIG

$454

Buy

22.08%

Upside

Reiterated

10/20/26

Intuitive Surgical: Strong Quarter and Resilient Growth Support Buy Rating and Unchanged $454 Price Target

Kendall Au

RBC Capital

$575→$550

Buy

47.89%

Upside

Reiterated

10/20/26

Intuitive Surgical (ISRG) Receives a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jayson Bedford

Raymond James

$483→$480

Buy

29.07%

Upside

Reiterated

10/21/26

Intuitive Surgical price target lowered to $480 from $483 at Raymond JamesIntuitive Surgical price target lowered to $480 from $483 at Raymond James

Adam Maeder

Piper Sandler

$470

Buy

26.38%

Upside

Reiterated

10/21/26

Piper Sandler Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Anthony Petrone

Mizuho Securities

$415→$400

Hold

7.56%

Upside

Reiterated

10/21/26

Intuitive Surgical price target lowered to $400 from $415 at MizuhoIntuitive Surgical price target lowered to $400 from $415 at Mizuho

Robbie Marcus

J.P. Morgan

$450→$475

Buy

27.72%

Upside

Assigned

10/21/26

Intuitive Surgical price target raised to $475 from $450 at JPMorganIntuitive Surgical price target raised to $475 from $450 at JPMorgan

Suraj Kalia

Oppenheimer

$500

Buy

34.44%

Upside

Reiterated

10/21/26

Intuitive Surgical (ISRG) Receives a Buy from Oppenheimer

Mike Kratky

Leerink Partners

$473→$503

Buy

35.25%

Upside

Reiterated

10/21/26

Intuitive Surgical price target raised to $503 from $473 at LeerinkIntuitive Surgical price target raised to $503 from $473 at Leerink

Christopher Pasquale

Barclays

$485→$500

Buy

34.44%

Upside

Reiterated

10/21/26

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Hans Engel

Erste Group

―

Buy

―

Upgraded

10/21/26

Intuitive Surgical upgraded to Buy from Hold at Erste GroupIntuitive Surgical upgraded to Buy from Hold at Erste Group

David Rescott

Robert W. Baird

$513→$550

Buy

47.89%

Upside

Reiterated

10/21/26

Intuitive Surgical price target raised to $550 from $513 at BairdIntuitive Surgical price target raised to $550 from $513 at Baird

Larry Biegelsen

Wells Fargo

$487→$486

Buy

30.68%

Upside

Assigned

10/21/26

Wells Fargo Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

$470

Buy

26.38%

Upside

Reiterated

10/21/26

Intuitive Surgical: Strong Q3 Beat, Extended-Use Instruments and 2027 Pipeline Drive Buy Rating with Unchanged $470 Target

Rick Wise

Stifel Nicolaus

$550

Buy

47.89%

Upside

Reiterated

10/21/26

Stifel Nicolaus Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Lee Hambright

Bernstein

$685

Buy

84.19%

Upside

Reiterated

10/21/26

Intuitive Surgical: Buy Rating Reaffirmed as Strong Fundamentals and Innovation Pipeline Support Unchanged $685 Price Target

Ryan Zimmerman

BTIG

$454

Buy

22.08%

Upside

Reiterated

10/20/26

Intuitive Surgical: Strong Quarter and Resilient Growth Support Buy Rating and Unchanged $454 Price Target

Kendall Au

RBC Capital

$575→$550

Buy

47.89%

Upside

Reiterated

10/20/26

Intuitive Surgical (ISRG) Receives a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AXGNAxoGen

SIBNSI-Bone

AORTArtivion

PHVSPharvaris

HELPHelus Pharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

Mike KratkyLeerink Partners

Success Rate

13/15 ratings generated profit

Average Return

+13.29%

Copying Mike Kratky's trades and holding each position for 3 Months would result in 86.67% of your transactions generating a profit, with an average return of +13.29% per trade.

1 Year

Joanne WuenschCiti

Success Rate

23/28 ratings generated profit

Average Return

+21.52%

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +21.52% per trade.

2 Years

Joanne WuenschCiti

Success Rate

25/28 ratings generated profit

Average Return

+39.32%

Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 89.29% of your transactions generating a profit, with an average return of +39.32% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0R29 Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0R29 has received 35 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 0R29 average Analyst price target in the past 3 months is 498.26.

Each month's total comprises the sum of three months' worth of ratings.

0R29 Financial Forecast

0R29 Earnings Forecast

Next quarter’s earnings estimate for 0R29 is $2.95 with a range of $2.85 to $3.04. The previous quarter’s EPS was $3.00. 0R29 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Sales Forecast

Next quarter’s sales forecast for 0R29 is $3.24B with a range of $3.12B to $3.29B. The previous quarter’s sales results were $3.05B. 0R29 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Stock Forecast FAQ

What is GB:0R29’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 498.26.

What is GB:0R29’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 33.98% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy, which is based on 18 buy ratings, 2 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 498.26. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $685.00 ,and the lowest forecast is $391.00. The average share price target represents 33.98% Increase from the current price of $371.9.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of GB:0R29, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (0R29) Share Forecast & Price Target

0R29 Analyst Ratings

0R29 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

0R29 Analyst Recommendation Trends

0R29 Financial Forecast

0R29 Earnings Forecast

0R29 Sales Forecast

0R29 Stock Forecast FAQ

Detailed List of Analyst Forecasts